- Research Grants
Fabricio Ferreira de Oliveira, MD, BBA, MSc, PhD, is the Medical Director of the Elysian Clinic in São Paulo, Medical Researcher of the Department of Neurology and Neurosurgery of the Federal University of São Paulo - UNIFESP, a Medical Doctor and a Bachelor in Business Administration, Master of Sciences in Medical Sciences (Neurology), Philosopher Doctor in Medicine (Neurology), Internist at the A. C. Camargo Cancer Center, Elected Member of the ISTAART Advisory Council (Alzheimer's Association, 2018-2020) and of the Executive Committee of the ISTAART Biofluid Based Biomarkers Professional Interest Area (Alzheimer's Association, 2018-2020), HealthCare Council Member for Gerson Lehrman Group (GLG) and for Atheneum Partners. He has been awarded the following prizes in the field of Neurology: 2019 Vascular Cognitive Disorders Professional Interest Area 3MT Competition (Alzheimer's Association, Los Angeles/USA), 2018 Travel Grant Award (MDS - International Parkinson and Movement Disorder Society, Hong Kong/CHINA), 2018 Travel Fellowship (Alzheimer's Association, Chicago/USA), 2017 Global Brain Health Institute Scholarship (GBHI - Global Brain Health Institute, Barcelona/SPAIN), 2016-2017 Who's Who in Science and Engineering (Marquis Who's Who, 12th edition, USA), 2016 Travel Fellowship (Alzheimer's Association, Toronto/CANADA), 2014 Travel Fellowship (Alzheimer's Association, Copenhagen/DENMARK), 2014 Who's Who in the World (Marquis Who's Who, 31st edition, USA), 2011-2012 Who's Who in Medicine and HealthCare (Marquis Who's Who, 8th edition, USA), Fundo de Auxílio aos Docentes e Alunos 2011 (UNIFESP - Escola Paulista de Medicina, São Paulo/BRAZIL), 2009 International Scholarship Award (AAN - American Academy of Neurology, Seattle/USA), Prêmio Roberto Melaragno Filho 2009 (APM/AMB - Associação Paulista de Medicina/Associação Paulista de Neurologia, Guarujá/BRAZIL), Desafio NeuroCiências 2009 (UNICAMP - State University of Campinas, Campinas/BRAZIL), 2008 Scholarship for Young Physicians (WSO/WHO - World Stroke Organization/World Health Organization, Vienna/AUSTRIA) and 2005 Federation Bursary (WFN - World Federation of Neurology, Sydney/AUSTRALIA). He is certified by CREMESP and the Brazilian Academy of Neurology as an expert in Internal Medicine (Medical Residency at the Federal University of Rio de Janeiro : 03/2000-02/2002) and Neurology (Medical Residency at the State University of Campinas : 02/2005-01/2007). He was previously an affiliate professor (2016-2019) of the Department of Neurology and Neurosurgery of the Federal University of São Paulo, a post-doctoral fellow (2015-2018) from The State of São Paulo Research Foundation - FAPESP, a senior physician (2002-2004) and the leader of the Brain Injured Patients' Rehabilitation Program (4th floor - 64 beds) at the SARAH Network of Rehabilitation Hospitals - SARAH Brasília. His medical graduation was from 1994 to 1999 at the State University of Rio de Janeiro, and his business administration graduation was from 2006 to 2009 at the Pontifical Catholic University of Campinas. He is a member of the International Society to Advance Alzheimer's Research and Treatment, of the International Parkinson and Movement Disorder Society, of the American Academy of Neurology, and of the Brazilian Academy of Neurology. He has worked with 152 collaborators in his scientific and professional activities. He has been a member of the editorial board and/or reviewer for 55 international medical journals, for the de Leon Prize in Neuroimaging and the Alzheimer Award, besides advising the Ministry of Health, The State of Rio Grande do Sul Research Foundation - FAPERGS and The State of Tocantins Research Foundation - FAPT in Brazil, as well as the Times Higher Education World Reputation Rankings, the European Science Foundation, the Elsevier Advisory Panel and the Kudos Preview Program, and reviewing abstracts for several events from the AAIC - Alzheimer's Association International Conference. (Source: Lattes Curriculum)
The objective of this cross-sectional study consists on the comparative analysis of cerebrospinal fluid and serum biomarkers among controls without dementia, patients with dementia with Lewy bodies, and patients with probable Alzheimer's disease dementia, seeking to better discriminate between these dementia syndromes and contrast with people without cognitive impairment. At least 26 su...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|